| NCT03409315 |
Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients |
https://ClinicalTrials.gov/show/NCT03409315 |
Recruiting |
University Medical Center Groningen |
2020-11-30 |
| NCT03383211 |
Immune Response to BCG Vaccination in Neonates Born to HIV and LTBI Infected and Non-infected Mothers |
https://ClinicalTrials.gov/show/NCT03383211 |
Active, not recruiting |
George Washington University |
2019-09-01 |
| NCT03305991 |
Tuberculosis Infection in Women of Reproductive Age and Their Infants |
https://ClinicalTrials.gov/show/NCT03305991 |
Active, not recruiting |
Lund University |
2021-01-01 |
| NCT03303963 |
DIAgnostics for Multidrug Resistant Tuberculosis in Africa |
https://ClinicalTrials.gov/show/NCT03303963 |
Recruiting |
Laboratoire de Référence des Mycobactéries |
2020-12-31 |
| NCT03228095 |
Volatiles in Breath and Headspace Analysis - Diagnostic Markers |
https://ClinicalTrials.gov/show/NCT03228095 |
Enrolling by invitation |
University of Latvia |
2019-12-20 |
| NCT03211208 |
Assessing Antibiotic Induced Liver Injury for Stratification of Tuberculosis Patients |
https://ClinicalTrials.gov/show/NCT03211208 |
Recruiting |
University of Edinburgh |
2020-04-30 |
| NCT03137875 |
Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis |
https://ClinicalTrials.gov/show/NCT03137875 |
Completed |
Epicentre |
2012-12-31 |
| NCT03096379 |
MRI Differentiating Gut TB and Crohn’s |
https://ClinicalTrials.gov/show/NCT03096379 |
Completed |
The University of Hong Kong |
2018-12-30 |
| NCT03080012 |
Salivary Therapeutic Drug Monitoring of Anti-Tuberculosis Drugs |
https://ClinicalTrials.gov/show/NCT03080012 |
Completed |
University Medical Center Groningen |
2018-05-02 |
| NCT03072576 |
Accuracy and Feasibility of Xpert Ultra |
https://ClinicalTrials.gov/show/NCT03072576 |
Completed |
Foundation for Innovative New Diagnostics, Switzerland |
2017-03-31 |
| NCT03000517 |
PK of Levofloxacin in MDR-TB Patients |
https://ClinicalTrials.gov/show/NCT03000517 |
Completed |
University Medical Center Groningen |
2017-10-27 |
| NCT02984579 |
Line Probe Assay Evaluation Study |
https://ClinicalTrials.gov/show/NCT02984579 |
Completed |
Foundation for Innovative New Diagnostics, Switzerland |
2016-01-31 |
| NCT02978131 |
Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis |
https://ClinicalTrials.gov/show/NCT02978131 |
Completed |
Lille Catholic University |
2016-06-30 |
| NCT02875574 |
Improving the Management of Drug Resistant Tuberculosis in the UK |
https://ClinicalTrials.gov/show/NCT02875574 |
Completed |
University College, London |
2017-12-31 |
| NCT02759848 |
The Role of Tuberculosis in Chronic Obstructive Lung Disease |
https://ClinicalTrials.gov/show/NCT02759848 |
Completed |
Istanbul Medeniyet University |
2014-12-31 |
| NCT02758236 |
Tuberculosis Research of INA-RESPOND On Drug Resistance |
https://ClinicalTrials.gov/show/NCT02758236 |
Active, not recruiting |
Ina-Respond |
2021-12-31 |
| NCT02736864 |
Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae |
https://ClinicalTrials.gov/show/NCT02736864 |
Completed |
Federal University of Uberlandia |
2017-10-31 |
| NCT02729532 |
Effect of Xpert MTB/RIF on Patient Outcomes |
https://ClinicalTrials.gov/show/NCT02729532 |
Completed |
University of North Carolina, Chapel Hill |
2018-02-09 |
| NCT02727582 |
Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment |
https://ClinicalTrials.gov/show/NCT02727582 |
Active, not recruiting |
University of Cape Town |
2018-11-14 |
| NCT02712671 |
Testing for Tuberculosis in the United Kingdom HIV Infected Population |
https://ClinicalTrials.gov/show/NCT02712671 |
Active, not recruiting |
University College, London |
2016-02-29 |
| NCT02701439 |
SMF to Improve Performance of Microscopy for the Diagnosis of PTB in a High HIV Prevalence Setting |
https://ClinicalTrials.gov/show/NCT02701439 |
Completed |
Epicentre |
2014-06-30 |
| NCT02687529 |
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection |
https://ClinicalTrials.gov/show/NCT02687529 |
Completed |
QIAGEN Gaithersburg, Inc |
2015-11-07 |
| NCT02653404 |
IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection |
https://ClinicalTrials.gov/show/NCT02653404 |
Recruiting |
University of Siena |
2019-04-30 |
| NCT02597621 |
Biomarkers for Therapy Response in Drug-resistant Tuberculosis |
https://ClinicalTrials.gov/show/NCT02597621 |
Active, not recruiting |
Research Center Borstel |
2020-12-31 |
| NCT01547884 |
Effect of Filarial Infection on Immune Responses in Latent Tuberculosis |
https://ClinicalTrials.gov/show/NCT01547884 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04443283 |
The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET |
https://ClinicalTrials.gov/show/NCT04443283 |
Enrolling by invitation |
Peking University Third Hospital |
2022-12-30 |
| NCT01212003 |
Training Protocol on the Natural History of Tuberculosis |
https://ClinicalTrials.gov/show/NCT01212003 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02534727 |
Sputum Pharmacokinetics of TB Drugs and Bacterial Drug Resistance |
https://ClinicalTrials.gov/show/NCT02534727 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-01-11 |
| NCT02413931 |
Nosocomial Transmission of MDR-TB in Bucharest, Romania |
https://ClinicalTrials.gov/show/NCT02413931 |
Active, not recruiting |
Research Center Borstel |
2020-12-31 |
| NCT02383849 |
IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants |
https://ClinicalTrials.gov/show/NCT02383849 |
Completed |
International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
2020-02-14 |
| NCT02382107 |
A Blinded, Cross-sectional, Diagnostic Evaluation Study Performed in Pulmonary TB Suspects at the TB Dispensary for Sector 4 of the Marius-Nasta-Institute in Bucharest, Romania |
https://ClinicalTrials.gov/show/NCT02382107 |
Completed |
Ludwig-Maximilians - University of Munich |
2016-05-31 |
| NCT02027480 |
Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study |
https://ClinicalTrials.gov/show/NCT02027480 |
Completed |
Columbia University |
2015-10-31 |
| NCT02274389 |
A Prospective Patient Registry of Patients Exposed to Bedaquiline |
https://ClinicalTrials.gov/show/NCT02274389 |
Completed |
Janssen Research & Development, LLC |
2018-11-20 |
| NCT02256839 |
Evaluation of the QuantiFERON-TB Test. |
https://ClinicalTrials.gov/show/NCT02256839 |
Completed |
QIAGEN Gaithersburg, Inc |
2015-10-31 |
| NCT02253537 |
Evaluation of the QuantiFERON-TB Test. |
https://ClinicalTrials.gov/show/NCT02253537 |
Completed |
QIAGEN Gaithersburg, Inc |
2016-04-26 |
| NCT02252198 |
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests |
https://ClinicalTrials.gov/show/NCT02252198 |
Completed |
Johns Hopkins University |
2015-01-31 |
| NCT02251327 |
Feasibility and Accuracy of a Novel Xpert Cartridge |
https://ClinicalTrials.gov/show/NCT02251327 |
Completed |
Johns Hopkins University |
2015-06-15 |
| NCT02176772 |
Iron Absorption and Utilization During Tuberculosis and After Treatment |
https://ClinicalTrials.gov/show/NCT02176772 |
Completed |
Swiss Federal Institute of Technology |
2017-01-31 |
| NCT02170441 |
Global Consortium for Drug-resistant Tuberculosis Diagnostics |
https://ClinicalTrials.gov/show/NCT02170441 |
Completed |
University of California, San Diego |
2014-06-30 |
| NCT02169141 |
Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients |
https://ClinicalTrials.gov/show/NCT02169141 |
Completed |
University Medical Center Groningen |
2013-02-28 |
| NCT02156882 |
Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique |
https://ClinicalTrials.gov/show/NCT02156882 |
Completed |
Ludwig-Maximilians - University of Munich |
2016-05-31 |
| NCT02142894 |
Evaluation of the QuantiFERON-TB Test. |
https://ClinicalTrials.gov/show/NCT02142894 |
Completed |
QIAGEN Gaithersburg, Inc |
2016-03-28 |
| NCT02135289 |
The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID |
https://ClinicalTrials.gov/show/NCT02135289 |
Completed |
Chinese University of Hong Kong |
2019-07-31 |
| NCT01317654 |
Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone |
https://ClinicalTrials.gov/show/NCT01317654 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2008-04-30 |
| NCT01311999 |
Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis |
https://ClinicalTrials.gov/show/NCT01311999 |
Completed |
National Taiwan University Hospital |
2013-11-30 |
| NCT01301144 |
Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis |
https://ClinicalTrials.gov/show/NCT01301144 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02043067 |
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV |
https://ClinicalTrials.gov/show/NCT02043067 |
Completed |
University of North Carolina, Chapel Hill |
2012-09-30 |
| NCT01866579 |
Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography |
https://ClinicalTrials.gov/show/NCT01866579 |
Completed |
Yonsei University |
2014-05-31 |
| NCT01850043 |
The Epidemiology of TST Change in Korea |
https://ClinicalTrials.gov/show/NCT01850043 |
Completed |
Asan Medical Center |
2012-05-31 |
| NCT01748357 |
Siemens VOC TB Pilot Study |
https://ClinicalTrials.gov/show/NCT01748357 |
Completed |
Research Center Borstel |
2013-12-31 |
| NCT03350048 |
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB |
https://ClinicalTrials.gov/show/NCT03350048 |
Enrolling by invitation |
University of Stellenbosch |
2019-06-30 |
| NCT01622140 |
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis |
https://ClinicalTrials.gov/show/NCT01622140 |
Active, not recruiting |
Centers for Disease Control and Prevention |
2021-04-30 |
| NCT01616264 |
Reproducibility of Computed Tomography |
https://ClinicalTrials.gov/show/NCT01616264 |
Completed |
Universidade Federal do Rio de Janeiro |
2009-10-31 |
| NCT01611402 |
Gene Expression in HIV and Tuberculosis Co-infection |
https://ClinicalTrials.gov/show/NCT01611402 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01608685 |
Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01608685 |
Completed |
Ligue Pulmonaire Genevoise |
2011-12-31 |
| NCT01601275 |
Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection |
https://ClinicalTrials.gov/show/NCT01601275 |
Completed |
Singapore General Hospital |
2018-05-31 |
| NCT01587677 |
Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis |
https://ClinicalTrials.gov/show/NCT01587677 |
Completed |
Research Center Borstel |
2012-11-30 |
| NCT01587469 |
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects |
https://ClinicalTrials.gov/show/NCT01587469 |
Completed |
Cepheid |
2014-02-21 |
| NCT01585532 |
Alere Mycobacterium Tuberculosis Urine Study |
https://ClinicalTrials.gov/show/NCT01585532 |
Completed |
Research Center Borstel |
2013-08-31 |
| NCT01560078 |
Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion |
https://ClinicalTrials.gov/show/NCT01560078 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2011-10-31 |
| NCT01539005 |
Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy |
https://ClinicalTrials.gov/show/NCT01539005 |
Completed |
Centre for the AIDS Programme of Research in South Africa |
2014-04-23 |
| NCT01492595 |
Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda |
https://ClinicalTrials.gov/show/NCT01492595 |
Completed |
Epicentre |
2014-04-30 |
| NCT01456845 |
Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity |
https://ClinicalTrials.gov/show/NCT01456845 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2012-06-30 |
| NCT01434758 |
Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture |
https://ClinicalTrials.gov/show/NCT01434758 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2014-12-31 |
| NCT01433796 |
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment |
https://ClinicalTrials.gov/show/NCT01433796 |
Completed |
Lund University |
2013-05-31 |
| NCT01422798 |
An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda |
https://ClinicalTrials.gov/show/NCT01422798 |
Completed |
Epicentre |
2014-12-31 |
| NCT01392365 |
Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn’s Disease |
https://ClinicalTrials.gov/show/NCT01392365 |
Completed |
Asan Medical Center |
2015-02-28 |
| NCT01390987 |
Access to Care and Adherence Tuberculosis (TB) Survey |
https://ClinicalTrials.gov/show/NCT01390987 |
Completed |
Azienda Ospedaliera San Gerardo di Monza |
2012-09-30 |
| NCT01376843 |
Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers |
https://ClinicalTrials.gov/show/NCT01376843 |
Completed |
Yonsei University |
2012-05-31 |
| NCT01371916 |
Diagnosis of Tuberculous Meningitis by ESAT-6 in CSF |
https://ClinicalTrials.gov/show/NCT01371916 |
Completed |
Xijing Hospital |
2013-11-30 |
| NCT01364324 |
Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients |
https://ClinicalTrials.gov/show/NCT01364324 |
Recruiting |
National Cancer Center, Korea |
2020-06-30 |
| NCT04434976 |
Delayed Diagnosis of Bacteriologically Positive Pulmonary Tuberculosis and Relative Optimized Suggestions in China |
https://ClinicalTrials.gov/show/NCT04434976 |
Completed |
Huashan Hospital |
2019-11-02 |
| NCT04342598 |
Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India |
https://ClinicalTrials.gov/show/NCT04342598 |
Recruiting |
Harvard School of Public Health |
2020-09-30 |
| NCT04208789 |
Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis |
https://ClinicalTrials.gov/show/NCT04208789 |
Recruiting |
Hasanuddin University |
2020-09-30 |
| NCT04148053 |
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis |
https://ClinicalTrials.gov/show/NCT04148053 |
Recruiting |
Tongji University |
2019-12-31 |
| NCT04147676 |
Evaluation of Centralised TB Assay Solutions |
https://ClinicalTrials.gov/show/NCT04147676 |
Recruiting |
Foundation for Innovative New Diagnostics, Switzerland |
2020-08-01 |
| NCT04179344 |
Usability Study of IeHS in Indonesia |
https://ClinicalTrials.gov/show/NCT04179344 |
Completed |
Bekasi City Public Hospital |
2019-10-31 |
| NCT03819374 |
Improving HIV/Tuberculosis Outcomes in Irkutsk |
https://ClinicalTrials.gov/show/NCT03819374 |
Recruiting |
University of Virginia |
2020-05-31 |
| NCT04089423 |
FujiLAM Prospective Evaluation Trial |
https://ClinicalTrials.gov/show/NCT04089423 |
Recruiting |
Foundation for Innovative New Diagnostics, Switzerland |
2021-02-28 |
| NCT04052022 |
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection |
https://ClinicalTrials.gov/show/NCT04052022 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-04-30 |
| NCT04015713 |
Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset |
https://ClinicalTrials.gov/show/NCT04015713 |
Recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2021-03-31 |
| NCT03993093 |
Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre |
https://ClinicalTrials.gov/show/NCT03993093 |
Completed |
Singh, Ranjan Kumar, M.D. |
2020-02-28 |
| NCT01269268 |
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis |
https://ClinicalTrials.gov/show/NCT01269268 |
Completed |
Yonsei University |
2014-05-14 |
| NCT03941210 |
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients |
https://ClinicalTrials.gov/show/NCT03941210 |
Recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-03-01 |
| NCT03929705 |
Assessing the Ability of the T-SPOT®.TB Test |
https://ClinicalTrials.gov/show/NCT03929705 |
Active, not recruiting |
Oxford Immunotec |
2020-04-30 |
| NCT03927664 |
Clinico-radiological Classification of Peritoneal Tuberculosis |
https://ClinicalTrials.gov/show/NCT03927664 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-04-30 |
| NCT03923231 |
Pharmacokinetics of Atazanavir in Special Populations |
https://ClinicalTrials.gov/show/NCT03923231 |
Recruiting |
University of Liverpool |
2022-05-31 |
| NCT03898635 |
Retrospective Real-word Study of Linezolid for the Treatment of Tuberculous Meningitis |
https://ClinicalTrials.gov/show/NCT03898635 |
Recruiting |
Huashan Hospital |
2019-05-01 |
| NCT03827811 |
Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis |
https://ClinicalTrials.gov/show/NCT03827811 |
Recruiting |
University of Cape Town |
2021-08-31 |
| NCT03808636 |
Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections |
https://ClinicalTrials.gov/show/NCT03808636 |
Recruiting |
St George’s, University of London |
2019-03-31 |
| NCT03800407 |
Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection |
https://ClinicalTrials.gov/show/NCT03800407 |
Recruiting |
University of Florida |
2023-01-31 |
| NCT03800394 |
Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents |
https://ClinicalTrials.gov/show/NCT03800394 |
Recruiting |
University of Florida |
2022-08-31 |
| NCT03800381 |
Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet |
https://ClinicalTrials.gov/show/NCT03800381 |
Recruiting |
University of Florida |
2022-08-30 |
| NCT03794284 |
Multiplex PCR -Microarray-based Assay in the Detection of Mycobacterium |
https://ClinicalTrials.gov/show/NCT03794284 |
Recruiting |
Chinese University of Hong Kong |
2020-02-29 |
| NCT03767946 |
Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal |
https://ClinicalTrials.gov/show/NCT03767946 |
Recruiting |
Biomedical Research Center EPLS |
2019-12-20 |
| NCT03739736 |
TB Reduction Through ART and TB Screening Project |
https://ClinicalTrials.gov/show/NCT03739736 |
Enrolling by invitation |
London School of Hygiene and Tropical Medicine |
2021-04-30 |
| NCT03736278 |
Characteristics of Tuberculosis Infection in Rheumatic Disease |
https://ClinicalTrials.gov/show/NCT03736278 |
Completed |
National Taiwan University Hospital |
2018-11-30 |
| NCT03734172 |
Rapid and Accurate Diagnosis of Paediatric (RaPaed) TB - An AIDA (Assessment of Innovative Diagnostics and Algorithms for Early and Sensitive Detection of Acute TB) Platform Study |
https://ClinicalTrials.gov/show/NCT03734172 |
Recruiting |
Ludwig-Maximilians - University of Munich |
2021-12-31 |
| NCT03728725 |
Xpert MTB/XDR Clinical Evaluation Trial |
https://ClinicalTrials.gov/show/NCT03728725 |
Recruiting |
Foundation for Innovative New Diagnostics, Switzerland |
2020-07-31 |
| NCT03712709 |
Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test |
https://ClinicalTrials.gov/show/NCT03712709 |
Recruiting |
Foundation for Innovative New Diagnostics, Switzerland |
2019-09-30 |
| NCT03667742 |
Diagnosing of Acute Tuberculosis |
https://ClinicalTrials.gov/show/NCT03667742 |
Recruiting |
University Hospital, Basel, Switzerland |
2020-06-30 |
| NCT03559582 |
Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100) |
https://ClinicalTrials.gov/show/NCT03559582 |
Enrolling by invitation |
University of Virginia |
2019-09-30 |
| NCT03537170 |
Dietary Assessment and Prevalence of Refeeding Syndrome in High-risk TB Patients in Chhattisgarh, India |
https://ClinicalTrials.gov/show/NCT03537170 |
Completed |
Washington University School of Medicine |
2018-02-14 |
| NCT03507816 |
A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace |
https://ClinicalTrials.gov/show/NCT03507816 |
Recruiting |
University Hospital, Strasbourg, France |
2020-02-29 |
| NCT03470233 |
Deltyba Registry in MDR-TB Patients |
https://ClinicalTrials.gov/show/NCT03470233 |
Active, not recruiting |
Korea Otsuka Pharmaceutical Co., Ltd. |
2020-06-30 |
| NCT03459768 |
Cohort Study on People Who Inject Drugs in Senegal |
https://ClinicalTrials.gov/show/NCT03459768 |
Active, not recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-02-29 |
| NCT03458338 |
Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa |
https://ClinicalTrials.gov/show/NCT03458338 |
Completed |
University Hospital, Basel, Switzerland |
2011-05-30 |
| NCT03423550 |
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis |
https://ClinicalTrials.gov/show/NCT03423550 |
Recruiting |
Asan Medical Center |
2019-06-30 |
| NCT01252992 |
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis |
https://ClinicalTrials.gov/show/NCT01252992 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-02-21 |
| NCT01252537 |
Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia |
https://ClinicalTrials.gov/show/NCT01252537 |
Completed |
Lund University |
2012-03-31 |
| NCT01201941 |
Operational Assessment of Laboratory Information System for MDR-TB in Lima, Peru |
https://ClinicalTrials.gov/show/NCT01201941 |
Completed |
Brigham and Women’s Hospital |
2009-03-31 |
| NCT01167647 |
The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study |
https://ClinicalTrials.gov/show/NCT01167647 |
Completed |
Meir Medical Center |
2012-10-31 |
| NCT01162265 |
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection |
https://ClinicalTrials.gov/show/NCT01162265 |
Completed |
Public Health England |
2015-06-30 |
| NCT01137370 |
The Impact of Vitamin D on Tuberculosis Among Koreans |
https://ClinicalTrials.gov/show/NCT01137370 |
Completed |
Seoul National University Hospital |
2011-03-31 |
| NCT01121068 |
Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients |
https://ClinicalTrials.gov/show/NCT01121068 |
Completed |
Seoul National University Hospital |
2011-05-31 |
| NCT01099098 |
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB |
https://ClinicalTrials.gov/show/NCT01099098 |
Completed |
Seoul National University Hospital |
2011-01-31 |
| NCT01071603 |
Tuberculosis in China |
https://ClinicalTrials.gov/show/NCT01071603 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01053598 |
Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting |
https://ClinicalTrials.gov/show/NCT01053598 |
Completed |
Epicentre |
2012-09-30 |
| NCT01038830 |
QuantiFERON Change During Anti-tuberculosis Medication |
https://ClinicalTrials.gov/show/NCT01038830 |
Completed |
Armed Forces Capital Hospital, Republic of Korea |
2010-04-30 |
| NCT01021124 |
Latent Tuberculosis Infection in Bone Marrow Transplant Recipients |
https://ClinicalTrials.gov/show/NCT01021124 |
Completed |
Asan Medical Center |
2013-06-30 |
| NCT01002170 |
Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament |
https://ClinicalTrials.gov/show/NCT01002170 |
Completed |
Taipei Medical University WanFang Hospital |
2009-06-30 |
| NCT00982969 |
The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis |
https://ClinicalTrials.gov/show/NCT00982969 |
Completed |
Armed Forces Capital Hospital, Republic of Korea |
2009-10-31 |
| NCT00981071 |
The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure |
https://ClinicalTrials.gov/show/NCT00981071 |
Completed |
Armed Forces Capital Hospital, Republic of Korea |
2010-04-30 |
| NCT00979290 |
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs |
https://ClinicalTrials.gov/show/NCT00979290 |
Completed |
E-DA Hospital |
2009-11-30 |
| NCT00978510 |
Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital Environment |
https://ClinicalTrials.gov/show/NCT00978510 |
Completed |
Sociedade Cearense de Infectologia |
NA |
| NCT00962793 |
Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ Assay |
https://ClinicalTrials.gov/show/NCT00962793 |
Completed |
Yonsei University |
NA |
| NCT00962676 |
Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients |
https://ClinicalTrials.gov/show/NCT00962676 |
Completed |
Yonsei University |
2010-12-31 |
| NCT00947609 |
Improving Latent Tuberculosis (TB) Diagnosis in Thai Children |
https://ClinicalTrials.gov/show/NCT00947609 |
Completed |
South East Asia Research Collaboration with Hawaii |
2011-12-31 |
| NCT00929786 |
Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity |
https://ClinicalTrials.gov/show/NCT00929786 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2009-04-30 |
| NCT00889759 |
The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation |
https://ClinicalTrials.gov/show/NCT00889759 |
Completed |
Armed Forces Capital Hospital, Republic of Korea |
2009-01-31 |
| NCT00865826 |
Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals |
https://ClinicalTrials.gov/show/NCT00865826 |
Completed |
AIDS Clinical Trials Group |
2011-03-31 |
| NCT00834353 |
Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis |
https://ClinicalTrials.gov/show/NCT00834353 |
Completed |
Maulana Azad Medical College |
2008-03-31 |
| NCT00810446 |
Safety And Efficacy Of Rifabutin In HIV Patients |
https://ClinicalTrials.gov/show/NCT00810446 |
Completed |
Pfizer |
2018-03-31 |
| NCT01379066 |
Tuberculosis Volatile Organic Compounds |
https://ClinicalTrials.gov/show/NCT01379066 |
Completed |
Landon Pediatric Foundation |
2009-12-31 |
| NCT00803322 |
Improving Community Based Tuberculosis Care in Ethiopia |
https://ClinicalTrials.gov/show/NCT00803322 |
Completed |
University of Bergen |
2007-09-30 |
| NCT00814827 |
Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma |
https://ClinicalTrials.gov/show/NCT00814827 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03271567 |
Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT03271567 |
Completed |
Chinese University of Hong Kong |
2019-07-31 |
| NCT03259269 |
Expand New Drugs for TB [endTB] |
https://ClinicalTrials.gov/show/NCT03259269 |
Active, not recruiting |
Partners in Health |
2020-09-30 |
| NCT02619240 |
Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB |
https://ClinicalTrials.gov/show/NCT02619240 |
Completed |
Chinese University of Hong Kong |
2017-04-30 |
| NCT02097095 |
Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972) |
https://ClinicalTrials.gov/show/NCT02097095 |
Completed |
Aeras |
2016-11-30 |
| NCT00810407 |
Safety And Efficacy Of Rifabutin In Patients For Non-HIV Patients |
https://ClinicalTrials.gov/show/NCT00810407 |
Completed |
Pfizer |
2016-07-31 |
| NCT02175849 |
Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis |
https://ClinicalTrials.gov/show/NCT02175849 |
Completed |
Oxford University Clinical Research Unit, Vietnam |
2015-09-30 |
| NCT00772408 |
Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis |
https://ClinicalTrials.gov/show/NCT00772408 |
Completed |
Chang Gung Memorial Hospital |
2009-11-30 |
| NCT00763295 |
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV? |
https://ClinicalTrials.gov/show/NCT00763295 |
Completed |
Northwell Health |
2010-01-31 |
| NCT00756808 |
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes? |
https://ClinicalTrials.gov/show/NCT00756808 |
Completed |
Northwell Health |
2010-07-31 |
| NCT00707317 |
T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals |
https://ClinicalTrials.gov/show/NCT00707317 |
Completed |
Tuberculosis Network European Trialsgroup |
2011-05-31 |
| NCT00695734 |
Detection of Latent Tuberculosis in Hemodialysis Patients |
https://ClinicalTrials.gov/show/NCT00695734 |
Completed |
University Hospital, Geneva |
2008-01-31 |
| NCT00682045 |
Latent Tuberculosis Infection in Renal Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00682045 |
Completed |
Asan Medical Center |
2010-05-31 |
| NCT00645697 |
Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization |
https://ClinicalTrials.gov/show/NCT00645697 |
Completed |
Rafic Hariri University Hospital |
2008-03-31 |
| NCT00595907 |
Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis |
https://ClinicalTrials.gov/show/NCT00595907 |
Completed |
University Hospital, Geneva |
2006-07-31 |
| NCT00567151 |
Co-Infection of NTM in Patients With Smear Positive Pulmonary TB |
https://ClinicalTrials.gov/show/NCT00567151 |
Completed |
Seoul National University Hospital |
2008-12-31 |
| NCT00557765 |
Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area |
https://ClinicalTrials.gov/show/NCT00557765 |
Completed |
University Hospital, Geneva |
NA |
| NCT00507754 |
Latent Tuberculosis Infection in Cancer Patients |
https://ClinicalTrials.gov/show/NCT00507754 |
Completed |
M.D. Anderson Cancer Center |
2011-05-31 |
| NCT00472316 |
Innovative Approaches to Tuberculosis Control |
https://ClinicalTrials.gov/show/NCT00472316 |
Completed |
Johns Hopkins University |
2009-10-31 |
| NCT00421798 |
Rapid Characterization of Paucibacillary TB Along Tex/Mex Border |
https://ClinicalTrials.gov/show/NCT00421798 |
Completed |
The University of Texas Health Science Center, Houston |
2009-01-31 |
| NCT00414882 |
A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding |
https://ClinicalTrials.gov/show/NCT00414882 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2009-06-28 |
| NCT00341601 |
Multi-Drug Resistant Tuberculosis in Korea |
https://ClinicalTrials.gov/show/NCT00341601 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00346476 |
Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South Africa |
https://ClinicalTrials.gov/show/NCT00346476 |
Completed |
CIPRA SA |
2010-12-31 |
| NCT00340990 |
Immune Responses to Mycobacterium Tuberculosis |
https://ClinicalTrials.gov/show/NCT00340990 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00266383 |
The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population |
https://ClinicalTrials.gov/show/NCT00266383 |
Completed |
National Health Research Institutes, Taiwan |
NA |
| NCT00257907 |
Immune Response to Mycobacterium Tuberculosis Infection |
https://ClinicalTrials.gov/show/NCT00257907 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00201253 |
Expression of Tuberculosis in the Lung |
https://ClinicalTrials.gov/show/NCT00201253 |
Completed |
Rutgers, The State University of New Jersey |
2008-06-30 |
| NCT00173433 |
Exogenous Reinfection of Tuberculosis in Taiwan |
https://ClinicalTrials.gov/show/NCT00173433 |
Completed |
National Taiwan University Hospital |
2006-07-31 |
| NCT00170638 |
Tuberculosis Immunity in Children |
https://ClinicalTrials.gov/show/NCT00170638 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00149448 |
Effectiveness of the TB Contact Priority Model |
https://ClinicalTrials.gov/show/NCT00149448 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-03-31 |
| NCT00134342 |
Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations |
https://ClinicalTrials.gov/show/NCT00134342 |
Completed |
University Health Network, Toronto |
2005-04-30 |
| NCT00096681 |
Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa |
https://ClinicalTrials.gov/show/NCT00096681 |
Completed |
CIPRA SA |
2005-08-31 |
| NCT00054769 |
Diagnosing Tuberculosis in HIV Infected Children in Peru |
https://ClinicalTrials.gov/show/NCT00054769 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-02-28 |
| NCT00023439 |
TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment |
https://ClinicalTrials.gov/show/NCT00023439 |
Completed |
Centers for Disease Control and Prevention |
NA |
| NCT00000785 |
A Registry of Tuberculosis Cases in the CPCRA |
https://ClinicalTrials.gov/show/NCT00000785 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1994-06-30 |
| NCT00005742 |
Behavioral Interventions for Control of Tuberculosis |
https://ClinicalTrials.gov/show/NCT00005742 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005741 |
Indigenous Outreach Among Injection Drug Users to Treat and Control TB |
https://ClinicalTrials.gov/show/NCT00005741 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005740 |
TB Contact Investigation: Behavioral Intervention |
https://ClinicalTrials.gov/show/NCT00005740 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005739 |
Behavioral Interventions for Control of TB |
https://ClinicalTrials.gov/show/NCT00005739 |
Completed |
Columbia University |
2004-12-31 |
| NCT00005738 |
Promoting Adherence to TB Regimens in Latino Adolescents |
https://ClinicalTrials.gov/show/NCT00005738 |
Completed |
San Diego State University |
NA |
| NCT00005737 |
Tuberculosis Prophylaxis in the Homeless–A Controlled Trial |
https://ClinicalTrials.gov/show/NCT00005737 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00005379 |
Tuberculosis in a Multiethnic Inner City Population |
https://ClinicalTrials.gov/show/NCT00005379 |
Completed |
NYU Langone Health |
1999-07-31 |